Latent Raises $80M to Expand AI Medication Access Platform
This image was generated by AI and may not depict real events.
Latent, a San Francisco-based AI healthcare company, has raised $80 million in Series A funding to expand its AI medication access platform. The company's Clinical Reasoning Engine integrates patient data, payer rules, pharmacy operations, and clinical workflows to reduce delays and denials in healthcare.
Latent, a San Francisco-based AI healthcare company, has raised $80 million in funding. The company's platform, the Clinical Reasoning Engine, integrates patient data and clinical workflows. It helps over two million patients every year and is used by more than 45 health systems. The platform automates prior authorizations and clinical workflows, reducing denials by over 30%. Latent plans to use the funding to expand its footprint in US health systems and hire more staff. The company's AI system ensures that patients receive their medication quickly and reliably.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.